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http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2015, TaiwanAbstract The aerial application of malathion, a widely used organophosphate insecticide,
has raised public concerns about its potential adverse health effects. We, therefore, studied
the antigenotoxic potential of curcumin and carvacrol against malathion-induced DNA damage
using sister chromatid exchange (SCE) as a biomarker of genotoxicity. To observe the antige-
notoxic potential of curcumin and carvacrol, heparinized fresh blood from healthy individuals
was treated with 30 mg/mL of malathion in the presence of curcumin and carvacrol. Curcumin
at concentrations of 25 mg/mL and 50 mg/mL had significantly reduced (p < 0.05) the frequency
of SCE as compared to malathion-exposed sample. Similarly, carvacrol showed significant
(p < 0.05) antigenotoxic effect at concentrations of 2.5 mg/mL and 5.0 mg/mL against mala-
thion. We also studied the effect of GSTT1 and GSTM1 on the genotoxicity of malathion and
antigenotoxic potential of curcumin and carvacrol. We observed that there is a statistically sig-
nificant (p < 0.05) reduction in the frequency of SCE in case of curcumin and carvacrol as
compared to malathion, but we did not observe any significant relationship (p > 0.05) between
GSTT1 and GSTM1 polymorphism and the genotoxicity of malathion and antigenotoxic poten-
tial of curcumin and carvacrol.
Copyright ª 2015, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
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Antigenotoxic potential of curcumin and carvacrol 99IntroductionPesticides are widely used across the world, and in recent
years their utilization has increased. Exposure to pesticides
is omnipresent, not because of application of pesticides in
agriculture and contamination of foods, but due to the
widespread use of these products in and around house-
holds. Malathion is an organophosphate insecticide that is
extensively used in gardens and orchards, to control various
pests including the Mediterranean fruit fly. Positive conse-
quences for chromosomal damage were shown by
technical-grade malathion in five in vivo animal studies,
while two studies using purified malathion showed negative
results.1 Studies have generally focused on pesticide ap-
plicators, that are exposed to other pesticides in addition
to malathion and have substantiated for increased sister
chromatid exchanges (SCEs) and/or chromosome aberra-
tions (CAs).2 Our study focused on DNA damage caused by
malathion and its prevention by using curcumin and
carvacrol in human lymphocyte culture by considering SCE
as a biomarker of genotoxicity. SCE is a process, during DNA
replication, in which two sister chromatids break and rejoin
with one another, physically exchanging regions of the
parental strands in the duplicated chromosomes.3
Nutraceuticals (often referred to as phytochemicals or
functional foods) are natural, bioactive, chemical com-
pounds that have health-promoting, disease-preventing, or
medicinal properties. Curcumin (diferuloylmethane), a
polyphenol, is the active ingredient of the dietary spice
turmeric (Curcuma longa) and has been consumed for me-
dicinal purposes for thousands of years; it has persuasive
anticancer properties, as demonstrated in a plethora of
human cancer cell lines/animal carcinogenesis models.4 It
acts as a free radical scavenger and an antioxidant, inhib-
itinglipid peroxidation and oxidative DNA damage.5,6
Carvacrol is a terpene constituent of various essential oils
extracted from the family Labiatae, including Origanum
species. It has been shown to exhibit a range of biological
activities such as antibacterial, antifungal, insecticidal,
analgesic, and antioxidant activities.7e11 Carvacrol has also
been found to have inhibitory effects in various types of
tumorigenesis. It was found to inhibit 7, 12 dimethyl benz
(a) anthracene (DMBA)-induced tumorigenesis in rats and
the growth of melanomas in vitro.12 Ameliorative effects of
curcumin and carvacrol have been studied in mice and
human lymphocytes using various mutagens.13,14 It is now
well established through molecular epidemiological studies
that both genetic and environmental factors are respon-
sible for individual susceptibility to mutagen. Hereditary
differences in the effectiveness of detoxification/activa-
tion of carcinogens play a vital role in host susceptibility.
Glutathione S-transferases (GST) are one of the most
frequently studied polymorphisms concerning metabolism
of xenobiotics. As GST function widely in metabolic
detoxification of xenobiotics, their genetic polymorphism
can play an important role in determining individual
sensitivity to various reactive chemicals. GSTM1 and GSTT1
are members of the GST multigene family, and are mostly
concerned with the detoxification of a broad range of
environmental carcinogens, endogenously produced reac-
tive oxygen species, and lipid peroxidation products,
yielding excretable hydrophilic metabolites.15 The nullGSTM1 and GSTT1 increase genotoxicity risk.16 There are
very few in vitro studies showing the effect of genetic
polymorphism of GSTM1 and GSTT1 on the genotoxicity of
malathion. In our study, we investigated the effect of
GSTM1 and GSTT1 polymorphism and its relation with the
genotoxicity of malathion/antigenotoxicity of curcumin
and carvacrol, as measured by SCE frequency.
Materials and methods
Sample collection
Venous blood (5 mL) was taken from healthy individuals in
two separate vacutainer tubes containing sodium heparin
and dipotassium EDTA for lymphocyte culture set-up and
DNA extraction, respectively. All participants signed a
consent form and also filled a questionnaire about their
health status history. All the individuals participated in this
study were men of age group 18e30 years and were bona
fide resident of Haryana state, North India (Aryan race).
The protocol was duly approved by the Human Ethical
Committee of Kurukshetra University, Haryana, India.
Human lymphocyte culture
Short-term peripheral blood lymphocyte cultures were set
up using the earlier studied technique of Moorhead et al17
with minor modifications. Culture was set up in duplicate
by adding whole heparinized blood (0.4 mL) into 5 mL of
RPMI 1640 culture medium (Himedia, Mumbai, India) con-
taining L-glutamine (1%), fetal calf serum (20%) (Himedia),
penicillin (100 UI/mL), streptomycin (100 mg/mL) solution
(Himedia), and phytohemagglutinin (2%) (Bangalore Genei,
Bangalore, India). The cultures were incubated at 37C and
5% CO2 for 72 hours.
Sister chromatid exchange
For SCE analysis, after 24 hours of incubation, 5-bromo-2-
deoxyuridine (Sigma-Aldrich, Sigma-Aldrich Co, St. Louis,
MO, USA) was added to the culture at a final concentration
of 10 mg/mL. Malathion (Sigma-Aldrich) was added at the
beginning of culture in concentrations ranging from 10 mg/
mL to 50 mg/mL. Out of these concentrations, the maximum
genotoxic dose of malathion, i.e., 30 mg/mL, was chosen to
check the antigenotoxic effect of curcumin and carvacrol
(Sigma-Aldrich). To check the antigenotoxic potential of
curcumin and carvacrol against malathion, separate cul-
tures with various combinations of malathion and curcu-
min/carvacrol were set up. In one set-up, heparinized fresh
blood was treated with 30 mg/mL of malathion along with
25 mg/mL and 50 mg/mL of curcumin, while in another set-
up, 2.5 mg/mL and 5.0 mg/mL of carvacrol were added
against 30 mg/mL of malathion. Combined effect of both
curcumin and carvacrol was also observed against mala-
thion. Blood was also treated with curcumin and carvacrol
alone to check their genotoxic effects if any. Blood without
any mutagen/curcumin and carvacrol acted as a control,
while blood having dimethylsulfoxide was taken as a
negative control. The cultures were then incubated for 72
Table 1 Frequency of SCE/cell in cultured human lym-






Untreated 50 2.40  0.23
10 50 3.58  0.34
20 50 4.75  0.56
30 50 6.55  0.54*
40 50 No differentiation
*p < 0.05, significant as compared to untreated.
SCE Z sister chromatid exchange; SE Z standard error.
100 N. Kumar et al.hours at 37C and 5% CO2. Colchicine (Sigma-Aldrich) was
added 45 minutes prior to harvesting at a final concentra-
tion of 0.2 mg/mL. The cells were harvested by centrifu-
gation, and then treated with a hypotonic solution (0.075M
KCl) and fixed in methanol:acetic acid (3:1). From a sus-
pension of fixed cells, slides were prepared by the air
drying method, and stained with Hoechst 33258 (Sigma-
Aldrich) and 4% Giemsa stain (Himedia) solution following
the method of Perry and Wolff.18 For calculating the fre-
quency of SCE per cell, 50 metaphase plates were analyzed.
GSTM1 and GSTT1 genotyping
Genomic DNA was extracted from 200 mL of whole blood by
a DNA extraction kit (Bangalore Genei). Multiplex poly-
merase chain reaction (PCR) was used to detect the pres-
ence or absence of GSTM1 and GSTT1 genes. For the
purpose of internal control, a part of exon 7 of the
constitutional gene CYP1A1 was also coamplified. The
amplification reaction was carried out in a 25 mL volume
containing 50e100 ng of genomic DNA as a template,
20 pmol/mL of each primer (GenXbio, Genxbio Health Sci-
ences (P) Ltd., Delhi, India), 200mM of each dNTP (Banga-
lore Genei), 1X PCR buffer with 15mM/L MgCl2 (Bangalore
Genei), and 0.7 units of Taq polymerase (Bangalore Genei).
PCR was performed using the reaction mixture with primersFigure 1 Sister chromatid exchange (SCE) in (A)GSTM1 (Fw50-GAACTCCCTGAAAAGCTAAAGC-30 and Re50-
GTTGGGCTCAAATATACGGTGG-30); GSTT1 (Fw 50-
TTCCTTACTGGTCCTCACATCTC-30, Re 50-TCACGGGAT-
CATGGCCAGCA-30), and CYP1A1 (Fw 50-GAACTGCCACTT-
CAGCTGTCT-30 and Re 50-CAGCTGCATTTGGAAGTGCTC-30),
yielding a 312-bp product. A total of 35 temperature cycles
were used: 10 minutes at 94C, 1 minute at 94C, 30 sec-
onds at 59C, and 1 minute at 72C. The last elongation step
was extended to 10 minutes at 72C. PCR products were
analyzed in 2% agarose gel.
Statistical analysis
All treatments were performed in duplicate, and the results
were expressed as means  standard error. The Student t
test was used for calculating the statistical significance
using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
Results
Pesticides are substances meant for preventing, destroying,
or mitigating any pest. They are widely used by farmers and
reported to have genotoxic effects on their health. Keeping
in mind the adverse effects of pesticides, we studied the
protective effects of curcumin and carvacrol against mal-
athion. In order to assess the antigenotoxic potential of
curcumin and carvacrol, SCE was examined in human pe-
ripheral lymphocytes. Malathion, at various concentrations,
was observed alone for its mutagenicity. Out of these
concentrations, 30 mg/mL had shown significant increase in
SCE as compared to untreated sample (Table 1), and this
concentration was chosen further for analyzing the anti-
genotoxic potential of curcumin and carvacrol. Fig. 1 shows
the increased frequency of SCE in case of malathion-
treated samples in comparison to the untreated sample.
Antigenotoxic effect of curcumin and carvacrol was
analyzed by reducing SCE frequency in presence of mala-
thion. Curcumin at concentrations of 25 mg/mL and 50 mg/
mL had significantly reduced the SCE frequency as
compared to malathion (Table 2). Similarly, carvacrol haduntreated and (B) malathion-treated samples.






Control Untreated 50 2.67  0.13
Malathion 30 50 7.67  0.37*
Malathion þ curcumin 30 þ 25 50 5.02  0.17**
Malathion þ curcumin 30 þ 50 50 3.53  0.23**
Curcumin 25 50 2.51  0.15***
Curcumin 50 50 2.60  0.20***
DMSO (negative control) 20 50 2.32  0.17***
*p < 0.05, significant as compared to untreated control.
**p < 0.05, significant as compared to malathion treatment.
***p > 0.05, nonsignificant as compared to untreated control.
DMSO Z dimethylsulfoxide; SCE Z sister chromatid exchange; SE Z standard error.
Antigenotoxic potential of curcumin and carvacrol 101protective effect at concentrations 2.5 mg/mL and 5.0 mg/
mL (Table 3). Both curcumin and carvacrol were also
analyzed for any genotoxic effect in the absence of mala-
thion. None of these were observed to be genotoxic. The
combined effect of both curcumin and carvacrol was also
studied (Table 4). It was found that the reduction in SCE
frequencies was higher with a combined treatment of cur-
cumin and carvacrol than treatment with either of them
individually. However, this reduction was not found to be
significant.Table 3 Protective effect of carvacrol against human lymphocy
Treatments Concentrations used (mg/m
Control Untreated
Malathion 30
Malathion þ carvacrol 30 þ 2.5
Malathion þ carvacrol 30 þ 5.0
Carvacrol 2.5
Carvacrol 5.0
DMSO (negative control) 20
*p < 0.05, significant as compared to untreated control.
**p < 0.05, significant as compared to malathion treatment.
***p > 0.05, nonsignificant as compared to untreated control.
DMSO Z dimethylsulfoxide; SCE Z sister chromatid exchange; SE Z




Malathion þ curcumin 30 þ 25
Malathion þ curcumin 30 þ 50
Malathion þ carvacrol 30 þ 2.5
Malathion þ carvacrol 30 þ 5.0
Malathion þ curcumin þ carvacrol 30 þ 25 þ 2.5
Malathion þ curcumin þ carvacrol 30 þ 50 þ 5.0
*p < 0.05, significant as compared to untreated control.
**p < 0.05, significant as compared to malathion treatment.
***p > 0.05, nonsignificant as compared to curcumin and carvacrol al
SCE Z sister chromatid exchange; SE Z standard error.Effect of genetic polymorphism of GSTM1 and
GSTT1 on the genotoxicity of malathion and
antigenotoxicity of curcumin and carvacrol
Individuals having different genotypes respond differently
to environmental chemicals. Multiplex PCR was used to
detect the presence or absence of GSTM1 and GSTT1 ge-
notypes. The occurrence of GSTM1 and GSTT1 genes was
detected by the presence or absence of a band at 215 bp
and 480 bp, respectively. We studied the antigenotoxictes culture treated with malathion.
L) Metaphase scored SCE/cell  SE
50 2.72  0.22
50 7.06  0.38*
50 5.27  0.16**
50 3.65  0.17**
50 2.80  0.16***
50 3.00  0.16***
50 2.32  0.17***
standard error.
alathion-treated cultured human lymphocytes.
(mg/mL) Metaphase scored SCE/cell  SE
50 2.36  0.17
50 5.88  0.38*
50 5.02  0.17**
50 3.53  0.23**
50 5.27  0.16**
50 3.65  0.17**
50 4.62  0.28***
50 3.26  0.20***
one treatment against malathion.
102 N. Kumar et al.potential of curcumin and carvacrol against the genotox-
icity of malathion, and its relationship with GSTT1 and
GSTM1 genetic polymorphism. We observed no significant
effect of GSTM1 and GSTT1 polymorphism on the geno-
toxicity of malathion and antigenotoxicity of curcumin and
carvacrol (Table 5). It was found that individuals who are
non-null for both GSTM1 and GSTT1 genes have less geno-
toxicity in presence of malathion, as compared to those
who are null for both GSTM1 and GSTT1 genes or have
either one of them. However, genotoxicity was not found to
be significant. Similarly, curcumin was found to be more
antigenotoxic in individuals having GSTM1 and GSTT1 non-
null genotypes in comparison to those having GSTM1 and
GSTT1 null genotypes. However, this antigenotoxic effect
was not found to be significant.
We found that curcumin and carvacrol have anti-
genotoxic effects against malathion-induced genotoxicity,
while their combined treatment did not show any signifi-
cant reduction in frequencies of SCE as compared to their
separate treatment. It has also been observed that there is
no significant effect of GSTT1 and GSTM1 polymorphism on
the genotoxicity of malathion and antigenotoxicity of cur-
cumin and carvacrol.
Discussion
In the present study, we studied the antigenotoxic effect of
curcumin and carvacrol individually, as well as in combina-
tion, against the genotoxic damage caused by malathion,
using SCE as a biomarker of genotoxicity. An increase in the
genotoxic damage is associated with an increased overall
risk of cancer.19,20 SCE is a more sensitive indicator of gen-
otoxic effects.21 We observed that the cells exposed to
malathion at concentrations of 0e40 mg/mL for 72 hours had
shown a dose-dependent increase in the frequency of SCE.
Malathion at a concentration of 30 mg/mL induced a signif-
icant increase in SCE frequency, while its higher concen-
trations were lethal to cells. Similar findings have also been
reported in the literature. Malathion was also found to be




GSTT1 (non-null) 7.80  0.61
GSTT1 (null) 7.61  0.31
Relationship with GSTM1
GSTM1 (non-null) 7.46  0.76
GSTM1 (null) 7.40  0.50
Relationship with both GSTT1and GSTM1
GSTT1 (non-null), GSTM1 (non-null) 7.36  0.18
GSTT1 (null), GSTM1 (null) 7.90  0.80
GSTT1 (non-null), GSTM1 (null) 8.70  0.20
GSTT1 (null), GSTM1 (non-null) 7.56  0.04
*p > 0.05, nonsignificant as compared to GSTT1 non-null genotypes.
**p > 0.05, nonsignificant as compared to GSTM1 non-null genotypes.
***p > 0.05, nonsignificant as compared to GSTT1 and GSTM1 non-nu
****p > 0.05, nonsignificant as compared to GSTT1 non-null and GSTM(Bloch), using micronucleus and comet assay as a biomarker
of genotoxicity.22 Malathion at a concentration of 40 mg/mL
has been found to increase the number of SCEs in case of
human fetal fibroblasts. A double exposure to a malathion
concentration of 20 mg/mL resulted in an increase in SCE
frequency.23 A dose-dependent increase in the frequency of
SCE was reported in the Chinese hamster cell line treated
with malathion at concentrations of 0e80 mg/mL. It was
observed that a concentration of 40 mg/mL had significantly
increased the number of SCEs, while at a concentration of
80 mg/mL cells failed to differentiate.24 Moore et al25 re-
ported that malathion is genotoxic to human liver carcinoma
(HepG2) cells. They observed a significant increase in DNA
damage after exposure to 24mM malathion, using comet
assay. A dose-dependent increase in the frequency of CA as
well as SCE was also observed in a leukocyte culture treated
with 0.02 mg/mL, 0.2 mg/mL, 2 mg/mL, and 20 mg/mL of
malathion.2 Sobti et al26 also reported an increase in SCE in
human lymphoid cells treated with malathion.
The results of the present study support the anti-
genotoxic role of curcumin and carvacrol against mala-
thion. Curcumin, the active ingredient of turmeric, is well
known for its antioxidant property.27 The antioxidant
mechanism of curcumin is due to its conjugated structure,
having two methoxylated phenols.28 Its free-radical-
scavenging antioxidant property helps it in reducing geno-
toxic damage. Carvacrol is a predominant aromatic com-
pound found in oil of oregano. Little is known about its
genotoxicity. Stammatia et al29 reported that the genotoxic
potential of carvacrol was very weak both in Ames and in
DNA-repair test, although it causes DNA fragmentation in
Hep-2 cells. Antimutagenic effect of carvacrol may be due
to its antioxidant nature.11 Antimutagenic activity of
carvacrol against malathion might be due to changes in
membrane lipids and permeability of ion channels, which
inhibit the uptake of malathion into the cells.30
We observed that 25 mg/mL and 50 mg/mL of curcumin
had significantly reduced the genotoxic damage caused by
malathion, which support its antigenotoxic property. We
also observed that carvacrol had antigenotoxic effectstoxicity of curcumin and carvacrol against malathion.
Malathion (30 mg/mL) þ
curcumin (25 mg/mL)
Malathion (30 mg/mL) þ
carvacrol (2.5 mg/mL)
5.06  0.49 5.26  0.22
5.10  0.16* 5.00  0.27*
5.07  0.35 5.52  0.08
5.10  0.21** 5.07  0.29**
4.94  0.84 5.40  0.10
5.14  0.0.16*** 4.85  0.65***
5.30  0.21 4.90  0.50
4.70  0.10**** 5.60  0.19****
ll genotypes.
1 null genotypes.
Antigenotoxic potential of curcumin and carvacrol 103against malathion at concentrations of 2.5 mg/mL and
5.0 mg/mL, supporting its antitumorigenic activities.12
Combination of curcumin and carvacrol was also analyzed
against malathion. Combined treatment of both curcumin
and carvacrol had significantly reduced the frequency of
SCE as compared to malathion, but the results were not
significant in comparison to their separate treatments.
Curcumin has been reported to reduce the clastogenic
effects of gamma radiation in human lymphocytes cultured
under in vitro conditions. Exposure of lymphocytes pre-
treated with curcumin at 1 Gy and 2 Gy (SI unit of absorbed
dose of radiations) resulted in a decrease in SCE as
compared to untreated lymphocytes.31
Siddique et al14 suggested the protective role of curcu-
min against the genotoxic damage caused by tinidazole in
cultured human lymphocytes. Curcumin at doses of 5mM,
10mM, and 15mM had shown a dose-dependent decrease in
SCE/cell against 10 mg/mL of tinidazole. Ipek et al13 re-
ported that carvacrol inhibited the rate of SCE induced by
mitomycin C.
Individuals have different responses to environmental
chemicals due to their different genotypes. In the present
study, we studied the effect of GSTT1 and GSTM1 poly-
morphism on the genotoxicity of malathion and anti-
genotoxic effect of curcumin and carvacrol. We found no
significant effect of GSTM1 and GSTT1 polymorphism on
malathion-induced genotoxicity and antigenotoxicity of
curcumin and carvacrol. Similar to our findings, Guven
et al32 also reported that GSTM1 genotype did not influence
SCE and CA induced in vitro by benzopyrene. Onaran et al33
observed that the lack of the GSTM1 gene has no influence
on induction of micronuclei in human lymphocyte cultures
by benzopyrene. Similarly, no significant relationship was
found between polymorphism of CYP1A1, GSTM1, GSTT1,
and GSTP1 and genotoxicity of trichloroethylene under
both in vivo and in vitro conditions.34 The antigenotoxic
effects of curcumin and carvacrol against malathion have
not yet been not reported in the literature. To the best of
our knowledge, there is only one in vitro study reporting
the antigenotoxic effect of carvacrol against malathion-
induced genotoxicity. No studies have investigated the
antigenotoxic effect of curcumin and carvacrol against
malathion-induced genotoxicity in human peripheral blood
lymphocytes. Ours is the first report on this issue. Our study
suggests that curcumin and carvacrol can be used to com-
bat genotoxic effects of malathion.Conflicts of interest
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